126 related articles for article (PubMed ID: 22216705)
21. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
[TBL] [Abstract][Full Text] [Related]
22. [Medullary thyroid carcinoma].
Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
[TBL] [Abstract][Full Text] [Related]
23. Thyroid medullary carcinoma in a teenager with Cowden syndrome.
Koksal Y; Sahin M; Koksal H; Orhan D; Unal E; Alagoz E
Laryngoscope; 2007 Jul; 117(7):1180-2. PubMed ID: 17603316
[TBL] [Abstract][Full Text] [Related]
24. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
25. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
Allen SM; Bodenner D; Suen JY; Richter GT
Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
[TBL] [Abstract][Full Text] [Related]
27. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
[TBL] [Abstract][Full Text] [Related]
28. Paraganglioma-like medullary thyroid carcinoma: a rare entity.
Bockhorn M; Sheu SY; Frilling A; Molmenti E; Schmid KW; Broelsch CE
Thyroid; 2005 Dec; 15(12):1363-7. PubMed ID: 16405409
[TBL] [Abstract][Full Text] [Related]
29. Rising CEA levels in a patient with colon carcinoma: metachronous medullary thyroid cancer.
Göksu SS; Göksu UA; Gündüz S; Coskun HS
Int J Biol Markers; 2014 Jun; 29(2):e184-6. PubMed ID: 24425322
[TBL] [Abstract][Full Text] [Related]
30. Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B.
Zenaty D; Aigrain Y; Peuchmaur M; Philippe-Chomette P; Baumann C; Cornelis F; Hugot JP; Chevenne D; Barbu V; Guillausseau PJ; Schlumberger M; Carel JC; Travagli JP; Léger J
Eur J Endocrinol; 2009 May; 160(5):807-13. PubMed ID: 19240193
[TBL] [Abstract][Full Text] [Related]
31. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
Samulski TD; Livolsi VA; Montone K; Baloch Z
Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
[TBL] [Abstract][Full Text] [Related]
32. [Increased blood CEA level as initial manifestation of medullary thyroid carcinoma].
Behr TM; Becker W
Dtsch Med Wochenschr; 1999 Mar; 124(10):303-4. PubMed ID: 10191829
[No Abstract] [Full Text] [Related]
33. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.
Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Ito Y; Nakano K; Kuma K; Futami H; Yamaguchi K
World J Surg; 2002 Aug; 26(8):1023-8. PubMed ID: 12016484
[TBL] [Abstract][Full Text] [Related]
34. Carcino-embryonic antigen--no help with the differential diagnosis.
Cobben-Beld EG; Nortier JW; Kramer WL; van de Wiel A; Rodenburg CJ
Neth J Med; 1996 Mar; 48(3):96-9. PubMed ID: 8935750
[TBL] [Abstract][Full Text] [Related]
35. Long-term survivor without recurrence after resection of simultaneous solitary pancreatic metastasis from thyroid medullary carcinoma.
Hyodo M; Nagai H; Sata N; Ishitsuka T; Kurihara K; Yoshizawa K; Saitoh K
Hepatogastroenterology; 2003; 50(53):1687-8. PubMed ID: 14571817
[TBL] [Abstract][Full Text] [Related]
36. [Genetic testing for ret mutation for early diagnosis and treatment in familial medullary thyroid carcinoma: a case report].
Nagaoka H; Iino Y; Takei H; Maemura M; Horiguchi J; Horii Y; Matumoto H; Koibuchi Y; Ninomiya J; Yokoe T; Oyama T; Morishita Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():481-5. PubMed ID: 9589057
[TBL] [Abstract][Full Text] [Related]
37. Surgical management of medullary thyroid cancer.
Mazeh H; Sippel RS
Minerva Endocrinol; 2012 Dec; 37(4):329-34. PubMed ID: 23235189
[TBL] [Abstract][Full Text] [Related]
38. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
39. A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC).
Passos I; Stefanidou E; Meditskou-Eythymiadou S; Mironidou-Tzouveleki M; Manaki V; Magra V; Laskou S; Mantalovas S; Pantea S; Kesisoglou I; Sapalidis K
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208296
[No Abstract] [Full Text] [Related]
40. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.
Komminoth P; Kunz EK; Matias-Guiu X; Hiort O; Christiansen G; Colomer A; Roth J; Heitz PU
Cancer; 1995 Aug; 76(3):479-89. PubMed ID: 8625130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
